Privium Fund Management B.V. Alx Oncology Holdings Inc Transaction History
Privium Fund Management B.V.
- $354 Million
- Q2 2024
A detailed history of Privium Fund Management B.V. transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Privium Fund Management B.V. holds 396,966 shares of ALXO stock, worth $742,326. This represents 0.68% of its overall portfolio holdings.
Number of Shares
396,966Holding current value
$742,326% of portfolio
0.68%Shares
1 transactions
Others Institutions Holding ALXO
# of Institutions
122Shares Held
40.7MCall Options Held
518KPut Options Held
142K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$18.1 Million33.06% of portfolio
-
Vivo Capital, LLC Palo Alto, CA4.22MShares$7.89 Million3.76% of portfolio
-
Redmile Group, LLC San Francisco, CA4.04MShares$7.55 Million1.59% of portfolio
-
Vestal Point Capital, LP New York, NY3.6MShares$6.73 Million1.62% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$5.03 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $76.2M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...